Cannabis Report
Home > Boards > US Listed > Biotechs >

CytomX Therapeutics, Inc. (CTMX)

CTMX RSS Feed
Add CTMX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 3/7/2018 6:09:06 PM - Followers: 5 - Board type: Free - Posts Today: 0

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops novel class of antibody therapeutics based on its Probody technology platform that address clinically-validated cancer targets in immuno-oncology, such as PD-L1, as well as novel targets, comprising CD-166. In addition, it has strategic collaborations with Bristol-Myers Squibb Company, Pfizer Inc., ImmunoGen, Inc., and The University of Texas M. D. Anderson Cancer Center to develop selected Probody therapeutics. The company was founded in 2008 and is headquartered in South San Francisco, California.
Cannabis Report
CTMX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTMX News: Current Report Filing (8-k) 07/17/2018 04:12:37 PM
CTMX News: CytomX Therapeutics Announces Closing of Public Offering of Common Stock 07/17/2018 04:01:00 PM
CTMX News: CytomX Therapeutics Announces Pricing of Public Offering of Common Stock 07/12/2018 07:50:10 PM
CTMX News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 07/10/2018 04:11:13 PM
CTMX News: Current Report Filing (8-k) 07/10/2018 04:07:45 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#11   PFE dumps CTMX collaboration: #msg-139113088. DewDiligence 03/07/18 06:09:06 PM
#10   Has this company any drugs in the market? manisero66 03/03/18 12:20:40 PM
#9   $CTMX entering runway to the launchpad. ??. Few Maxgambit 11/17/17 11:46:20 AM
#8   CTMX $41 price target fl89808 10/04/17 12:54:33 PM
#7   Up 35% after hours! fl89808 10/03/17 08:00:05 PM
#6   Enough cash in the bank until 2020 as fl89808 08/08/17 10:08:54 PM
#4   $200 million in the bank. No cash raises fl89808 06/04/17 10:18:27 AM
#3   "As of March 31, 2017, CytomX had cash, fl89808 05/05/17 10:10:17 AM
#2   Bristol-Myers Squibb Company BMY and CytomX Therapeutics, Inc. fl89808 03/21/17 08:05:26 PM
#1   $200M up front payment coming with 36.5 million fl89808 03/20/17 08:06:01 PM
PostSubject